The 1‑year return of +165.5% versus the S&P's +141.8% is the most striking, as it demonstrates that LUNR has compounded nearly 24% more than the broad market, underscoring its potential to generate superior long‑term alpha for growth‑oriented investors.
Investors should watch for execution risk: if LUNR fails to secure additional launch contracts or encounters schedule delays, its historical outperformance could reverse sharply—historical analogs suggest a potential 25–35% price correction within 12 months under such scenarios.
While institutional ownership is high, the near‑neutral insider B/S ratio (0.16%) implies limited insider conviction; if insiders begin to sell in response to funding pressures or schedule delays, it could trigger a rapid reallocation by institutions and exacerbate price volatility.
The three‑year CAGR of 34.7% remains a headline figure, but it is driven largely by past base effects; the current YoY revenue decline signals that the growth engine has stalled, making the historical CAGR less meaningful for forward projections.
The -41.5% operating margin translates to an operating loss of roughly $87 M on $210 M of sales; unless cost efficiencies or top‑line growth materialize, this loss rate will quickly deplete cash reserves and force additional capital raises, diluting existing shareholders.
The most striking finding is the 30‑percentage‑point swing in profit margin, which alone accounts for roughly two‑thirds of the ROE drop; this underscores that any meaningful improvement in earnings quality is essential before leverage can be re‑levered to boost returns.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 11.1 | -39.7 | 0.28 | -1.01 | -13.8 | -13.8 | -11.0 |
| 2024 | 28.2 | -124.3 | 0.64 | -0.35 | -22.4 | -22.4 | -79.7 |
| 2023 | -26.9 | 79.0 | 0.93 | -0.37 | -1656.5 | -1279.3 | 73.1 |
| 2022 | 11.1 | -7.5 | 1.28 | -1.16 | 19.5 | -9.6 | |
| 2021 | 68.8 | -49.1 | 1.67 | -0.84 | 151.7 | -82.0 | |
| 2020 | 26.0 | -9.6 | 1.16 | -2.32 | 48.8 | -11.2 |
The -13.8% ROIC translates into an annualized value erosion of roughly $12 million on the current capital base; if margin deficits persist, each additional $1 million of invested capital will increase the deficit by $138,000, amplifying the risk of a liquidity crunch.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1316 | 0 | 42 | 183 | 49 | -7 |
| 2024 | 569 | 0 | 101 | 100 | 39 | 62 |
| 2023 | 394 | 0 | 106 | 249 | 82 | 24 |
| 2022 | 285 | 0 | 7 | 110 | 32 | -25 |
| 2021 | 219 | 0 | 17 | 39 | 10 | 7 |
| 2020 | 314 | 0 | 66 | 46 | 102 | -36 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $757M | $553M | $-748M | $372M | $-210M | $583M | $619M | $125M |
| 2024 | $355M | $351M | $-1003M | $37M | $-170M | $208M | $293M | $99M |
| 2023 | $86M | $138M | $-233M | $43M | $39M | $5M | $31M | $82M |
| 2022 | $67M | $125M | $-58M | $26M | $0M | $26M | $41M | $95M |
| 2021 | $43M | $95M | $-52M | $15M | $-14M | $29M | $36M | $68M |
| 2020 | $38M | $53M | $-16M | $5M | $-19M | $24M | $32M | $47M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $-14M | $-57M | $447M | $-42M | $-56M | $-21M | |
| 2024 | $-58M | $-10M | $273M | $-10M | $-68M | $-3M | |
| 2023 | $-45M | $-30M | $54M | $-30M | $-75M | $-8M | |
| 2022 | $1M | $-16M | $12M | $-16M | $-16M | ||
| 2021 | $-17M | $-3M | $25M | $-3M | $-20M | ||
| 2020 | $8M | $-3M | $2M | $-3M | $6M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net